Recovery and Analysis of Bacterial Membrane Vesicle Nanoparticles from Human Plasma Using Dielectrophoresis

Jason P Ware1,2, Delaney K Shea1,2, Shelby L Nicholas1

  • 1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97201, USA.

Biosensors
|October 25, 2024
PubMed

Insights

Researchers developed a new method using dielectrophoretic (DEP) forces to rapidly isolate bacterial membrane vesicles (BMVs) from human plasma. This technique enhances biomarker recovery for improved pathogen identification in clinical diagnostics.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Clinical Diagnostics

Background:

  • Bacterial membrane vesicles (BMVs) are valuable biomarkers but difficult to recover from biological fluids.
  • Traditional BMV recovery methods are time-consuming and low-yield, hindering clinical applications.

Purpose of the Study:

  • To develop a rapid and efficient method for isolating and analyzing BMVs from human plasma.
  • To enable improved pathogen identification using BMVs as biomarkers.

Main Methods:

  • Utilized dielectrophoretic (DEP) forces on electrokinetic microfluidic chips to isolate BMVs.
  • Employed immunofluorescence staining for lipopolysaccharide (LPS) biomarker detection.
  • Analyzed BMVs from small volumes (25 µL) of human plasma.

Main Results:

  • Achieved rapid and consistent collection of BMVs from human plasma using DEP.
  • Demonstrated a lower limit of detection of 4.31 × 10^9 BMVs/mL.
  • Successfully isolated and performed on-chip immunostaining of BMVs.

Conclusions:

  • DEP-based microfluidic chip enables efficient isolation of BMVs from complex biological fluids like plasma.
  • This method facilitates the development of novel diagnostic assays for bacterial pathogen identification.
  • Advances clinical diagnostics by enabling biomarker analysis from minimal sample volumes.

Related Concept Videos